All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Vansafe CP 1gm Injection
Prescription Required
Salt Composition : Vancomycin
Manufacturer : VHB LIFE SCIENCES INC
Origin of Medicine : India
1 Vial(s)
Introduction to Vansafe Cp 1gm Injection
Vansafe CP 1gm Injection contains an active component as Vancomycin. It is effective against Gram-positive bacteria, including MRSA, Streptococcus, Enterococcus, and other drug-resistant strains. This broad spectrum of activity makes it useful in treating various serious infections. This is considered a "last-resort" antibiotic, used when other antibiotics fail or when the infection is known or suspected to be caused by resistant bacteria. Some patients may be allergic to certain antibiotics, limiting treatment options. Vansafe CP 1gm Injection can be an alternative for those who cannot tolerate other antibiotic classes. It is used prophylactically in certain situations to prevent infections in high-risk patients, such as those undergoing certain surgical procedures or with a history of recurrent infections.
Vansafe CP 1gm Injection should not be used in patients with known hypersensitivity or severe allergic reactions to the drug. Allergic reactions can be life-threatening and may include symptoms such as rash, itching, swelling, severe dizziness, and difficulty breathing. Patients with a history of hearing impairment or hearing loss related to this medication use should not receive the medication unless necessary. It is primarily eliminated from the body through the kidneys. Therefore, caution is required when administering Vansafe CP 1gm Injection to patients with severe renal impairment. In such cases, dosage adjustments or alternative treatments may be necessary to prevent further kidney damage. This medication use in infants, especially premature infants, should be closely monitored, as they may be more susceptible to potential side effects or toxicity.
Uses of Vansafe Cp 1gm Injection
Vansafe CP 1gm Injection is used in the treatment of the following:
- Methicillin-resistant staphylococcus aureus (MRSA) infections
- Serious skin and soft tissue infections
- Endocarditis
- Bone and joint infections
- Bacterial bloodstream infections
- Pneumonia
- Surgical prophylaxis
- Clostridium difficile infection
Therapeutic Effects of Vansafe Cp 1gm Injection
Vansafe CP 1gm Injection works by interfering with the bacterial cell wall synthesis. Bacterial cells have a rigid outer layer called the cell wall, which provides structural support and protects the cell from bursting. It binds to specific components in the cell wall, preventing the formation of a stable cell wall structure. As a result, the bacterial cell becomes weak and more susceptible to damage, leading to its death.
Interaction of Vansafe Cp 1gm Injection with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Vansafe CP 1gm Injection, reducing effectiveness by causing undesirable side effects.Â
More Information about Vansafe Cp 1gm Injection
- Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Vansafe Cp 1gm Injection
Healthcare professionals typically administer Vansafe CP 1gm Injection in a hospital or clinical setting. The injection may be given as a slow infusion or intermittent intravenous (IV), depending on the treatment condition and the healthcare provider's instructions. Before administration, the healthcare professional will assess the patient's patient's medical history, current health status, and any known allergies or sensitivities.Â
Safety Advices for Vansafe Cp 1gm Injection
 Â
Pregnancy
 Â
It is essential for pregnant women to consult with their healthcare providers about the potential risks and benefits of using Vansafe CP 1gm Injection during pregnancy.Â
 Â
Breast Feeding
 ÂVansafe CP 1gm Injection can pass into breast milk, but the amount transferred is usually minimal. If this medication is used during breastfeeding, the healthcare provider will assess the risks and benefits and may monitor the baby for any adverse effects.
 Â
Lungs
 Â
Vansafe CP 1gm Injection is primarily used for respiratory conditions and is generally considered safe for the lungs when used as directed. But patients with lung disease should consult a doctor before using it.
 Â
Liver
 Â
Vansafe CP 1gm Injection can be used in patients with liver impairment, but caution is required, and dosage adjustments may be necessary.Â
 Â
Alcohol
 ÂBoth Vansafe CP 1gm Injection and alcohol can have potential side effects on their own. When combined, there is an increased risk of adverse reactions, including nausea, vomiting, dizziness, and gastrointestinal disturbances. Alcohol may also exacerbate some of the side effects, such as kidney or liver toxicity.
 Â
Driving
  Vansafe CP 1gm Injection may cause side effects that can impair driving ability and overall alertness. Common side effects include dizziness, headache, and tremors, which can affect coordination and reaction time.
Side Effects of Vansafe Cp 1gm Injection
Vansafe CP 1gm Injection cause some side effects like all medications, although not everyone will experience them.Â
Serious:
- Allergic reactions
- Kidney damage
- Ear damage
- Severe allergic reaction
- Severe diarrhea
- Fever
- Blood disorders
- Hemorrhagic occlusive retinal vasculitis
Common:
- Nausea and vomiting
- Diarrhea
- Rash or itching
- Redness or swelling at the injection site
- Fever or chills
- Headache
- Low blood pressure
Word of Advice
Patients should inform their healthcare providers about any known allergies or previous adverse reactions to Vansafe CP 1gm Injection or other antibiotics. Close monitoring of kidney and liver function is essential, especially in patients with pre-existing conditions affecting these organs. Proper dosage adjustment is crucial, considering factors such as the patient's weight, age, and renal function. Patients should complete the full course of treatment as prescribed, even if they start feeling better. Pregnant and breastfeeding women should consult their healthcare providers before using it. Patients should promptly report any severe or concerning side effects experienced during treatment. This medication should be used cautiously in the elderly and pediatric populations, with dosages adjusted accordingly. These precautions aim to maximize the benefits of this medication while minimizing the risk of side effects and antibiotic resistance.
FAQs
Q 1. What are the common side effects of Vansafe CP 1gm Injection?
Common side effects of Vansafe CP 1gm Injection include nausea, vomiting, diarrhea, rash, redness or swelling at the injection site, fever, headache, and low blood pressure.
Q 2. Can Vansafe CP 1gm Injection cause hearing loss?
Yes, in rare cases, Vansafe CP 1gm Injection can cause hearing loss or ringing in the ears (tinnitus), especially in patients with pre-existing hearing impairment or those receiving high doses or prolonged treatment.
Q 3. How is Vansafe CP 1gm Injection dosed?
Vansafe CP 1gm Injection dosing is based on various factors, including the type of infection, the patient's weight, age, kidney function, and the severity of the infection. The dosing regimen is typically determined by healthcare providers.
Q 4. Can Vansafe CP 1gm Injection be given to children?
Yes, Vansafe CP 1gm Injection can be used in children, but the dosing must be adjusted based on the child's weight and kidney function. Pediatric patients should be closely monitored during treatment.
Q 5. What is the risk of Vansafe Vancomycin-resistant bacteria?
Overuse or misuse of Vansafe CP 1gm Injection can contribute to the development of Vancomycin-resistant bacteria, which is a significant concern in healthcare settings.
Q 6. How long should Vansafe CP 1gm Injection treatment be continued?
The duration of Vansafe CP 1gm Injection treatment depends on the specific infection being treated and the patient's response to the medication. The full course of treatment should be completed as prescribed, even if symptoms improve.
Fact Box of Vansafe Cp 1gm Injection
Molecule name: Vancomycin | Therapeutic class: Antibiotics |
Pharmacological class:Â Glycopeptide antibiotics | Indications:Â 1. Methicillin-resistant staphylococcus aureus (MRSA) infections 2. Serious skin and soft tissue infections 3. Endocarditis 4. Bone and joint infections 5. Bacterial bloodstream infections 6. Pneumonia 7. Surgical prophylaxis 8. Clostridium difficile infection |
References
- Strides Pharma UK Ltd, Electronic Medicines Compendium (EMC), [Revised on 4 Dec 2022] [Accessed on 28th July 2023], https://www.medicines.org.uk/emc/product/14318/pil#gref
- Mylan Institutional LLC, FDA (Food and Drug Safety Administration) [Revised on July 2018], [Accessed on 28th July 2023] https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209481s000lbl.pdf
- Camille E. Beauduy, Lisa G. Winston, Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics, Lange’s Basic & Clinical Pharmacology, 14th Edition, 2018, 795-814.
- KD Tripathi, Macrolide, Lincosamide, Glycopeptide and other Antibacterial Antibiotics, Essentials of Medical Pharmacology, 8th Edition, 2019, 801-814.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
